Skip to content

Energy-efficient and Health Promoting Light for Elderly People

A Study of Two Different Light Conditions for Healthy Subjects Above 65 Years

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02216318
Acronym
light-age
Enrollment
29
Registered
2014-08-13
Start date
2013-10-31
Completion date
2013-12-31
Last updated
2018-08-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Sleep

Keywords

sleep, circadian, melatonine, pupil response

Brief summary

to investigate the effect of two lightning conditions on sleep hypothesizing that sleep length is influenced by the color of light during daytime

Detailed description

Lightning conditions seems to be important for the length and quality of sleep, as light have an influence on the production of the sleep hormone (melatonin) and the the circadian rhythm. Entrainment of the circadian rhythm to the surroundings is accomplished by light-sensitive retinal ganglion cells and these cells are sensitive to blue light. Based on previous research, blue light early in the day and abscence of blue light during evening is important for the entrainment. In this study, lightning conditions in the home of healthy subjects are set to either blue enriched or red enriched from 8 a.m to 1. p.m. The lightning condition is based on a randomization protocol in a cross-over study for 3 weeks in each condition, separated by a one week pause.

Interventions

Sponsors

Elforsk
CollaboratorUNKNOWN
Albertslund Kommune
CollaboratorUNKNOWN
Gate 21
CollaboratorUNKNOWN
DTU Fotonik
CollaboratorUNKNOWN
VISO systems
CollaboratorUNKNOWN
AF Lightning
CollaboratorUNKNOWN
Philips Healthcare
CollaboratorINDUSTRY
Statens Byggeforskningsinstitut
CollaboratorUNKNOWN
Glostrup University Hospital, Copenhagen
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
65 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* age 65 to 85 years

Exclusion criteria

* Conditions which will interfere by the primary endpoint as evaluated by the medical doctor

Design outcomes

Primary

MeasureTime frameDescription
Sleep length1 weekThe mean of sleep length during the last week of each light period

Secondary

MeasureTime frameDescription
actigraphy1 weekmean sleep efficiency during the last week in each light period

Other

MeasureTime frameDescription
pupillometrythe last day of each light periodthe pupillary response to blue and red light
melatoninthe last day of each light periodtiming of melatonin onset
Questionnaire3 weeksQuestionnaire count

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026